Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer

Colorectal cancer (CRC) is a genetically, anatomically, and transcriptionally heterogeneous disease. The prognosis for a CRC patient depends on the stage of the tumor at diagnosis and widely differs accordingly. The tumor microenvironment (TME) in CRC is an important factor affecting targeted cancer...

Full description

Bibliographic Details
Main Authors: Gaetano Gallo, Giuseppina Vescio, Gilda De Paola, Giuseppe Sammarco
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/11/2295
_version_ 1797532731712733184
author Gaetano Gallo
Giuseppina Vescio
Gilda De Paola
Giuseppe Sammarco
author_facet Gaetano Gallo
Giuseppina Vescio
Gilda De Paola
Giuseppe Sammarco
author_sort Gaetano Gallo
collection DOAJ
description Colorectal cancer (CRC) is a genetically, anatomically, and transcriptionally heterogeneous disease. The prognosis for a CRC patient depends on the stage of the tumor at diagnosis and widely differs accordingly. The tumor microenvironment (TME) in CRC is an important factor affecting targeted cancer therapy. The TME has a dynamic composition including various cell types, such as cancer-associated fibroblasts, tumor-associated macrophages, regulatory T cells, and myeloid-derived suppressor cells, as well as extracellular factors that surround cancer cells and have functional and structural roles under physiological and pathological conditions. Moreover, the TME can limit the efficacy of therapeutic agents through high interstitial pressure, fibrosis, and the degradation of the therapeutic agents by enzymatic activity. For this reason, the TME is a fertile ground for the discovery of new drugs. The aim of this narrative review is to present current knowledge and future perspectives regarding the TME composition based on strategies for patients with CRC.
first_indexed 2024-03-10T11:03:28Z
format Article
id doaj.art-6d5aec0bb5a4485e8a9dba220e5bad9b
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T11:03:28Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-6d5aec0bb5a4485e8a9dba220e5bad9b2023-11-21T21:18:12ZengMDPI AGJournal of Clinical Medicine2077-03832021-05-011011229510.3390/jcm10112295Therapeutic Targets and Tumor Microenvironment in Colorectal CancerGaetano Gallo0Giuseppina Vescio1Gilda De Paola2Giuseppe Sammarco3 Department of Medical and Surgical Sciences, University of Catanzaro, Viale Europa, 88100 Catanzaro, Italy Department of Medical and Surgical Sciences, University of Catanzaro, Viale Europa, 88100 Catanzaro, Italy Department of Medical and Surgical Sciences, University of Catanzaro, Viale Europa, 88100 Catanzaro, ItalyDepartment of Health Sciences, University of Catanzaro, Viale Europa, 88100 Catanzaro, ItalyColorectal cancer (CRC) is a genetically, anatomically, and transcriptionally heterogeneous disease. The prognosis for a CRC patient depends on the stage of the tumor at diagnosis and widely differs accordingly. The tumor microenvironment (TME) in CRC is an important factor affecting targeted cancer therapy. The TME has a dynamic composition including various cell types, such as cancer-associated fibroblasts, tumor-associated macrophages, regulatory T cells, and myeloid-derived suppressor cells, as well as extracellular factors that surround cancer cells and have functional and structural roles under physiological and pathological conditions. Moreover, the TME can limit the efficacy of therapeutic agents through high interstitial pressure, fibrosis, and the degradation of the therapeutic agents by enzymatic activity. For this reason, the TME is a fertile ground for the discovery of new drugs. The aim of this narrative review is to present current knowledge and future perspectives regarding the TME composition based on strategies for patients with CRC.https://www.mdpi.com/2077-0383/10/11/2295tumor microenvironmentcolorectal cancertargeted therapyangiogenesistumor-associated macrophagesregulatory T cells
spellingShingle Gaetano Gallo
Giuseppina Vescio
Gilda De Paola
Giuseppe Sammarco
Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
Journal of Clinical Medicine
tumor microenvironment
colorectal cancer
targeted therapy
angiogenesis
tumor-associated macrophages
regulatory T cells
title Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
title_full Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
title_fullStr Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
title_full_unstemmed Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
title_short Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
title_sort therapeutic targets and tumor microenvironment in colorectal cancer
topic tumor microenvironment
colorectal cancer
targeted therapy
angiogenesis
tumor-associated macrophages
regulatory T cells
url https://www.mdpi.com/2077-0383/10/11/2295
work_keys_str_mv AT gaetanogallo therapeutictargetsandtumormicroenvironmentincolorectalcancer
AT giuseppinavescio therapeutictargetsandtumormicroenvironmentincolorectalcancer
AT gildadepaola therapeutictargetsandtumormicroenvironmentincolorectalcancer
AT giuseppesammarco therapeutictargetsandtumormicroenvironmentincolorectalcancer